Presentation on theme: "Vigabatrin: Vigabatrin, the first 'designer drug' in the epilepsy field, is a vinyl-substituted analogue of GABA acts by inhibitng GABA transaminase."— Presentation transcript:
Vigabatrin: Vigabatrin, the first 'designer drug' in the epilepsy field, is a vinyl-substituted analogue of GABA acts by inhibitng GABA transaminase effectve in patients unresponsive to conventional drugs main side-effects: drowsiness, behavioral and mood changes.. Drug interaction: decreases phenytoin conc.
Lamotrigine acts by inhibiting sodium channels broad therapeutic profile main side-effects are hypersensitivity reactions (especially skin rashes
FELBAMATE is an analogue of an obsolete anxiolytic drug, meprobamate M.O.A It has only a weak effect on sodium channels little effect on GABA block of the NMDA receptor channel.
FELBAMATE Acute side effects are mild, mainly nausea, irritability and insomnia, but it occasionally causes severe reactions resulting in aplastic anaemia or hepatitis. For this reason, its recommended use is limited to a form of intractable epilepsy in children (Lennox- Gastaut syndrome) that is unresponsive to other drugs. Its plasma half-life is about 24 hours, and it can enhance the plasma concentration of other AEDs given concomitantly.
Gabapentin action appears to be on T-type calcium channel function, by binding to a particular channel subunit (α2δ), and it inhibits the release of various neurotransmitters and modulators. The side effects of gabapentin (mainly sedation and ataxia) are less severe than with many antiepileptic drugs.
The absorption of gabapentin from the intestine depends on the amino acid carrier system and shows the property of saturability, which means that increasing the dose does not proportionately increase the amount absorbed. This makes gabapentin relatively safe and free of side effects associated with overdosing.
Its plasma half-life is about 6 hours, requiring dosing two to three times daily. It is excreted unchanged in the urine and is free of interactions with other drugs. It has limited efficacy when used on its own, so is used mainly as add-on therapy.
It is also used as an analgesic to treat neuropathic pain. A recently introduced follow-up drug, pregabalin, is more potent than gabapentin but otherwise very similar. These drugs are excreted unchanged in the urine, and so must be used with care in patients whose renal function is impaired.
Primidone MOA Converted into phenobarbital Na channels blocker Uses Partial seizure Tonic-clonic seizure Side effects Drowsiness Sedation
Tiagabine an analogue of GABA that is able to penetrate the blood-brain barrier, acts by inhibiting the reuptake of GABA by neurons and glia. It enhances the extracellular GABA concentration, as measured in microdialysis experiments, and also potentiates and prolongs GABA-mediated synaptic responses in the brain. It has a short plasma half-life, and its main side effects are drowsiness and confusion.
TIAGABINE MOA Blocks GABA reuptake Uses Partial seizure Side effects Drowsiness and confusion Tremors and difficulty to conc. Weakness of knees Agitation
Side effects Confusion Hyperthermia Ataxia Fatigue Dizziness Wt. gain N.B. long t1/2 (60 hrs.) Drug interactions: increases conc. of carbamazepine, its level is increased by enz. inducer
Levetiracetam MOA UNKNOWN Uses Generalized seizure Side effects Somnolence Ataxia Anxiety Agitation Decrease in RBC Advantages No drug interaction Can be used in hepatic and renal impairment
RUFINAMIDE Rufinamide is a triazole derivative structurally unrelated to other antiepileptic drugs. It appears to act by enhancing sodium channel inactivation and may also inhibit GABA reuptake. It is licensed for treating Lennox-Gastaut syndrome and may also be effective in partial seizures. It has low plasma protein binding and is not metabolised by CYP enzymes. STIRIPENTOL Stiripentol has some efficacy as an adjunctive therapy in children. It enhances GABA release and prolongs GABA- mediated synaptic events in a manner similar to phenobarbital
Antiepileptic drugs have proved to have much wider clinical applications than was originally envisaged, and clinical trials have shown many of them to be effective in the following conditions: cardiac dysrhythmias e.g. phenytoin bipolar disorder e.g. valproate, carbamazepine, oxcarbazepine, lamotrigine, topiramate migraine prophylaxis e.g. valproate, gabapentin, topiramate; anxiety disorders e.g. gabapentin; neuropathic pain e.g. gabapentin, carbamazepine, lamotrigine;
DEVELOPMENT OF NEW DRUGS There are a number of new antiepileptic agents currently being evaluated in clinical trials. Several of these appear to act by novel mechanisms. 1- Retigabine is an activator of neuronal KCNQ (K v 7) potassium channels that underlie the M current which controls membrane excitability. It also appears to be effective in treating some pain states. 2-Lacosamide may enhance sodium channel inactivation, but unlike other antiepileptic drugs it appears to affect slow rather than rapid inactivation processes. 3- Ganaxolone, structurally resembling endogenous neurosteroids, is a positive allosteric modulator of GABA A receptors containing δ subunits 4-Tonabersat is a neuronal gap junction inhibitor. The identification of epileptogenic mutations of genes encoding specific ion channels and other functional proteins is expected to lead to new drugs aimed at these potential targets-a field to watch.
ANTIEPILEPTIC DRUGS AND PREGNANCY There are several important implications for women taking antiepileptic drugs. By inducing hepatic CYP3A4 enzymes, some antiepileptic drugs may increase oral contraceptive metabolism, thus reducing their effectiveness. Taken during pregnancy, drugs such as phenytoin, carbamazepine, lamotrogine, topiramate and valproate are thought to produce teratogenic effects. It remains to be clarified if newer agents also have this problem. Induction of CYP enzymes may result in vitamin K deficiency in the newborn. Phenytoin, valproate and topiramate may also induce fetal abnormalities if taken during pregnancy.
Clinical uses of antiepileptic drugs Tonic-clonic (grand mal) seizures: carbamazepine (preferred because of a relatively favourable effectiveness:risk ratio), phenytoin, valproate use of a single drug is preferred, when possible, to avoid pharmacokinetic interactions newer agents include vigabatrin, lamotrigine, felbamate, gabapentin. Partial (focal) seizures: carbamazepine, valproate; alternatives are clonazepam or phenytoin.
Absence seizures (petit mal): ethosuximide or valproate valproate is used when absence seizures coexist with tonic-clonic seizures, because most other drugs used for tonic-clonic seizures can worsen absence seizures. Myoclonic seizures: diazepam intravenously or (in absence of accessible veins) rectally. Neuropathic pain: for example carbamazepine, gabapentin To stabilise mood in mono- or bipolar affective disorder (as an alternative to lithium ): for example carbamazepine, valproate
Conclusion Newer AEDs have higher effectiveness, better PK profile, less drug interactions and lower side effects which made them quite popular. However, more clinical studies are needed to clarify the teratogenicity and drug interactions
Side effects Drowsiness Motor incoordination Nausea Behavioral effects Caution Kidney diseases CV & respiratory diseases Peptic ulcer (CI)